08/05/2025 09:58
|
Biotechnology
8 May 2025 – Sydney, Australia | LTR Pharma Limited (ASX:LTP) has entered into a development agreement with US-based Strategic Drug Solutions, Inc. (SDS) to co-develop OROFLOW®, a novel intranasal...